These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25260849)

  • 1. TREM2 analysis and increased risk of Alzheimer's disease.
    Finelli D; Rollinson S; Harris J; Jones M; Richardson A; Gerhard A; Snowden J; Mann D; Pickering-Brown S
    Neurobiol Aging; 2015 Jan; 36(1):546.e9-13. PubMed ID: 25260849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triggering Receptor Expressed on Myeloid Cell 2 R47H Exacerbates Immune Response in Alzheimer's Disease Brain.
    Korvatska O; Kiianitsa K; Ratushny A; Matsushita M; Beeman N; Chien WM; Satoh JI; Dorschner MO; Keene CD; Bammler TK; Bird TD; Raskind WH
    Front Immunol; 2020; 11():559342. PubMed ID: 33101276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coding variants in TREM2 increase risk for Alzheimer's disease.
    Jin SC; Benitez BA; Karch CM; Cooper B; Skorupa T; Carrell D; Norton JB; Hsu S; Harari O; Cai Y; Bertelsen S; Goate AM; Cruchaga C
    Hum Mol Genet; 2014 Nov; 23(21):5838-46. PubMed ID: 24899047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. R47H TREM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementia.
    Slattery CF; Beck JA; Harper L; Adamson G; Abdi Z; Uphill J; Campbell T; Druyeh R; Mahoney CJ; Rohrer JD; Kenny J; Lowe J; Leung KK; Barnes J; Clegg SL; Blair M; Nicholas JM; Guerreiro RJ; Rowe JB; Ponto C; Zerr I; Kretzschmar H; Gambetti P; Crutch SJ; Warren JD; Rossor MN; Fox NC; Collinge J; Schott JM; Mead S
    Alzheimers Dement; 2014 Nov; 10(6):602-608.e4. PubMed ID: 25160042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease-associated R47H TREM2 increases, but wild-type TREM2 decreases, microglial phagocytosis of synaptosomes and neuronal loss.
    Popescu AS; Butler CA; Allendorf DH; Piers TM; Mallach A; Roewe J; Reinhardt P; Cinti A; Redaelli L; Boudesco C; Pradier L; Pocock JM; Thornton P; Brown GC
    Glia; 2023 Apr; 71(4):974-990. PubMed ID: 36480007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia.
    Ruiz A; Dols-Icardo O; Bullido MJ; Pastor P; Rodríguez-Rodríguez E; López de Munain A; de Pancorbo MM; Pérez-Tur J; Alvarez V; Antonell A; López-Arrieta J; Hernández I; Tárraga L; Boada M; Lleó A; Blesa R; Frank-García A; Sastre I; Razquin C; Ortega-Cubero S; Lorenzo E; Sánchez-Juan P; Combarros O; Moreno F; Gorostidi A; Elcoroaristizabal X; Baquero M; Coto E; Sánchez-Valle R; Clarimón J;
    Neurobiol Aging; 2014 Feb; 35(2):444.e1-4. PubMed ID: 24041969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TREM2 R47H variant and risk of essential tremor: a cross-sectional international multicenter study.
    Ortega-Cubero S; Lorenzo-Betancor O; Lorenzo E; Agúndez JA; Jiménez-Jiménez FJ; Ross OA; Wurster I; Mielke C; Lin JJ; Coria F; Clarimon J; Ezquerra M; Brighina L; Annesi G; Alonso-Navarro H; García-Martin E; Gironell A; Marti MJ; Yueh KC; Wszolek ZK; Sharma M; Berg D; Krüger R; Pastor MA; Pastor P
    Parkinsonism Relat Disord; 2015 Mar; 21(3):306-9. PubMed ID: 25585992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TREM2 variants in Alzheimer's disease.
    Guerreiro R; Wojtas A; Bras J; Carrasquillo M; Rogaeva E; Majounie E; Cruchaga C; Sassi C; Kauwe JS; Younkin S; Hazrati L; Collinge J; Pocock J; Lashley T; Williams J; Lambert JC; Amouyel P; Goate A; Rademakers R; Morgan K; Powell J; St George-Hyslop P; Singleton A; Hardy J;
    N Engl J Med; 2013 Jan; 368(2):117-27. PubMed ID: 23150934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TREM2 is associated with the risk of Alzheimer's disease in Spanish population.
    Benitez BA; Cooper B; Pastor P; Jin SC; Lorenzo E; Cervantes S; Cruchaga C
    Neurobiol Aging; 2013 Jun; 34(6):1711.e15-7. PubMed ID: 23391427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. R47H Variant of TREM2 Associated With Alzheimer Disease in a Large Late-Onset Family: Clinical, Genetic, and Neuropathological Study.
    Korvatska O; Leverenz JB; Jayadev S; McMillan P; Kurtz I; Guo X; Rumbaugh M; Matsushita M; Girirajan S; Dorschner MO; Kiianitsa K; Yu CE; Brkanac Z; Garden GA; Raskind WH; Bird TD
    JAMA Neurol; 2015 Aug; 72(8):920-7. PubMed ID: 26076170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TREM2 R47H variant as a risk factor for early-onset Alzheimer's disease.
    Pottier C; Wallon D; Rousseau S; Rovelet-Lecrux A; Richard AC; Rollin-Sillaire A; Frebourg T; Campion D; Hannequin D
    J Alzheimers Dis; 2013; 35(1):45-9. PubMed ID: 23380991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer's Disease Pathology in Down Syndrome.
    Raha-Chowdhury R; Henderson JW; Raha AA; Stott SRW; Vuono R; Foscarin S; Wilson L; Annus T; Fincham R; Allinson K; Devalia V; Friedland RP; Holland A; Zaman SH
    J Alzheimers Dis; 2018; 61(3):1143-1162. PubMed ID: 29278889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and processing analyses of wild type and p.R47H TREM2 variant in Alzheimer's disease brains.
    Ma L; Allen M; Sakae N; Ertekin-Taner N; Graff-Radford NR; Dickson DW; Younkin SG; Sevlever D
    Mol Neurodegener; 2016 Nov; 11(1):72. PubMed ID: 27887626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TREM2 and the neuroimmunology of Alzheimer's disease.
    Hickman SE; El Khoury J
    Biochem Pharmacol; 2014 Apr; 88(4):495-8. PubMed ID: 24355566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frontobasal gray matter loss is associated with the TREM2 p.R47H variant.
    Luis EO; Ortega-Cubero S; Lamet I; Razquin C; Cruchaga C; Benitez BA; Lorenzo E; Irigoyen J; ; Pastor MA; Pastor P
    Neurobiol Aging; 2014 Dec; 35(12):2681-2690. PubMed ID: 25027412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TREM2 variants and risk of Alzheimer's disease: a meta-analysis.
    Lu Y; Liu W; Wang X
    Neurol Sci; 2015 Oct; 36(10):1881-8. PubMed ID: 26037549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis.
    Cady J; Koval ED; Benitez BA; Zaidman C; Jockel-Balsarotti J; Allred P; Baloh RH; Ravits J; Simpson E; Appel SH; Pestronk A; Goate AM; Miller TM; Cruchaga C; Harms MB
    JAMA Neurol; 2014 Apr; 71(4):449-53. PubMed ID: 24535663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of triggering receptor expressed on myeloid cells 2 variant in the Wisconsin Registry for Alzheimer's Prevention.
    Engelman CD; Koscik RL; Jonaitis EM; Hermann BP; La Rue A; Sager MA
    Neurobiol Aging; 2014 Jun; 35(6):1252-4. PubMed ID: 24378087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia.
    Cuyvers E; Bettens K; Philtjens S; Van Langenhove T; Gijselinck I; van der Zee J; Engelborghs S; Vandenbulcke M; Van Dongen J; Geerts N; Maes G; Mattheijssens M; Peeters K; Cras P; Vandenberghe R; De Deyn PP; Van Broeckhoven C; Cruts M; Sleegers K;
    Neurobiol Aging; 2014 Mar; 35(3):726.e11-9. PubMed ID: 24119542
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Durmanova V; Javor J; Parnicka Z; Minarik G; Ocenasova A; Vaseckova B; Kiralyova I; Sutovsky S; Petrovic R; Shawkatova I
    J Integr Neurosci; 2022 Jun; 21(4):105. PubMed ID: 35864757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.